Our specialists provide advanced care for patients with chronic wounds resulting from conditions including chronic venous stasis, arterial insufficiency, diabetes, vasculitis, hypercoagulable states, and a range of complex dermatologic and medical conditions. The Center has a particular focus on pyoderma gangrenosum. Our experts use innovative treatment approaches to restore angiogenesis balance in these conditions, including:
Recombinant growth factor therapy, cytokine inducers, and TNF-alpha inhibitor biologics
Matrix metalloprotease inhibitors
Thalidomide, retinoids, vitamin D3 analogs, and Cox-2 inhibitors
Tissue engineered skin cell therapy
The Center helps patients avoid limb amputation through advanced outpatient therapies. Patients receive clinical evaluation and diagnosis, office debridement, bacterial bioburden management, advanced dressings, and bioactive treatment modalities as an integral part of their care.